AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹5,526 Cr | ₹3,925 Cr | ₹2,435 Cr | ₹2,387 Cr | ₹5,016 Cr |
What is the latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹5,526 Cr |
| Mar2025 | ₹3,925 Cr |
| Mar2024 | ₹2,435 Cr |
| Mar2023 | ₹2,387 Cr |
| Mar2022 | ₹5,016 Cr |
How is Cash Flow from Operating Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,526 Cr | 40.81 | |
| Mar2025 | ₹3,925 Cr | 61.21 | |
| Mar2024 | ₹2,435 Cr | 2.00 | |
| Mar2023 | ₹2,387 Cr | -52.42 | |
| Mar2022 | ₹5,016 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹103,629.5 Cr | -0.2% | 11.5% | 48.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.2% |
11.5% |
48.3% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses